{
    "nctId": "NCT03504865",
    "briefTitle": "Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo",
    "officialTitle": "Single-Blinded, Randomized Assessment of Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo",
    "overallStatus": "UNKNOWN",
    "conditions": "Mastectomy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Postop pain and satisfaction scores",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. All female patients over 18\n2. Subjects must be scheduled to undergo bilateral therapeutic or prophylactic skin or nipple-sparing mastectomy at Medstar Georgetown University Hospital\n3. Subjects must have immediate reconstruction consisting of either tissue expander placement or direct implant placement at the time of mastectomy\n4. subjects are capable of giving informed consent\n\nExclusion Criteria:\n\n1. Subjects cannot be homeless persons\n2. Subjects cannot have active drug/alcohol dependence or abuse history.\n3. Subjects cannot be pregnant\n4. Subjects cannot have documented chronic or recent opioid use as well as chronic pain syndromes\n5. We will exclude any patients who will plan to undergo postoperative whole breast radiation\n6. Subjects cannot have bupivacaine (and all related analog) allergies",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}